TIDM0QCV TIDM0Y7T 
 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                14(th) April 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                69,695,919  4.71979% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  69,695,919  4.71979% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,200                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               400                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                            32,303                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,000                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,400                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               500                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               400                    81.86 
--------------  -----------------------------  ----------------------- 
   Purchase                               260                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                           296,926                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                           101,388                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                             2,784                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               864                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               325                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               130                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               267                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               564                    82.13 
--------------  -----------------------------  ----------------------- 
   Purchase                               125                    81.30 
--------------  -----------------------------  ----------------------- 
     Sale                                 678                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                               4,400                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                               1,000                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                                 500                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                              16,600                    82.38 
--------------  -----------------------------  ----------------------- 
     Sale                              21,900                    82.38 
--------------  -----------------------------  ----------------------- 
     Sale                               4,700                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                                 600                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                               2,385                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                               6,270                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                               1,100                    82.13 
--------------  -----------------------------  ----------------------- 
     Sale                                 534                    82.13 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       15(th) April 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ----------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ----------------- 
 
 
 
 
 
 

(END) Dow Jones Newswires

April 15, 2020 10:58 ET (14:58 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Allergan Charts.
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Allergan Charts.